Oocyte donation for reproduction and research cloning--the perils of commodification and the need for European and international regulation.
The demand for women's egg cells is increasing and is leading to reproductive tourism and transnational oocyte trafficking. The article considers the regulatory landscape of oocyte donation in Europe and analyses different types, particularly whether oocytes are provided within or outside of the IVF context, and whether anonymity of the donor is legally possible or not. The bifurcation between different purposes of egg extraction, particularly the challenges raised by ova demands for cloning research (SCNT) are highlighted. In emphasizing the need for supranational regulation, nine rules for supranational minimum standards are proposed to protect both donor interests and the public good. A particular focus is directed to the commodification of oocytes with regard to the European principle of non-commercial, voluntary and altruistic donation.
Schneider
Ingrid
I
FSP BIOGUM, Center for Biotechnology, Society and the Environment-Medicine/Neuronal Sciences, University of Hamburg, Hamburg, Germany. Ingrid.Schneider@uni-hamburg.de
D000329:Advertising; D019976:Cloning, Organism; D032821:Commodification; D005060:Europe; D005260:Female; D005307:Fertilization in Vitro; D036281:Genetic Research; D006801:Humans; D007258:Informed Consent; D018587:Oocyte Donation / Q000191:economics / Q000941:ethics / Q000331:legislation & jurisprudence; D027724:Reproductive Techniques, Assisted; D014019:Tissue Donors